NCT03132311View on ClinicalTrials.gov

Immunogenicity and Safety of the Yellow Fever Vaccine in HIV Infected Individuals

PHASE4RecruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

May 29, 2017

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2028

Conditions
HIV Infections
Interventions
BIOLOGICAL

Yellow Fever vaccination (17 DD Biomanguinhos)

One intramuscular injection

Trial Locations (1)

21040360

RECRUITING

Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro

All Listed Sponsors
lead

Oswaldo Cruz Foundation

OTHER